237 related articles for article (PubMed ID: 38257728)
1. The Functional Roles of MDSCs in Severe COVID-19 Pathogenesis.
Len JS; Koh CWT; Chan KR
Viruses; 2023 Dec; 16(1):. PubMed ID: 38257728
[TBL] [Abstract][Full Text] [Related]
2. Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions.
Siemińska I; Węglarczyk K; Surmiak M; Kurowska-Baran D; Sanak M; Siedlar M; Baran J
Front Immunol; 2021; 12():748097. PubMed ID: 34659245
[TBL] [Abstract][Full Text] [Related]
3. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).
Agrati C; Sacchi A; Bordoni V; Cimini E; Notari S; Grassi G; Casetti R; Tartaglia E; Lalle E; D'Abramo A; Castilletti C; Marchioni L; Shi Y; Mariano A; Song JW; Zhang JY; Wang FS; Zhang C; Fimia GM; Capobianchi MR; Piacentini M; Antinori A; Nicastri E; Maeurer M; Zumla A; Ippolito G
Cell Death Differ; 2020 Nov; 27(11):3196-3207. PubMed ID: 32514047
[TBL] [Abstract][Full Text] [Related]
4. Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19.
Jiménez-Cortegana C; Sánchez-Jiménez F; Pérez-Pérez A; Álvarez N; Sousa A; Cantón-Bulnes L; Vilariño-García T; Fuentes S; Martín S; Jiménez M; León-Justel A; de la Cruz-Merino L; Garnacho-Montero J; Sánchez-Margalet V
Front Immunol; 2021; 12():801410. PubMed ID: 35154077
[TBL] [Abstract][Full Text] [Related]
5. Correlation of myeloid-derived suppressor cells with C-reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID-19.
Emsen A; Sumer S; Tulek B; Cizmecioglu H; Vatansev H; Goktepe MH; Kanat F; Koksal Y; Arslan U; Artac H
Scand J Immunol; 2022 Jan; 95(1):e13108. PubMed ID: 34625989
[TBL] [Abstract][Full Text] [Related]
6. Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19.
Koushki K; Salemi M; Miri SM; Arjeini Y; Keshavarz M; Ghaemi A
Biomed Pharmacother; 2021 Dec; 144():112346. PubMed ID: 34678727
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19.
Rowlands M; Segal F; Hartl D
Front Immunol; 2021; 12():697405. PubMed ID: 34220859
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotype and function of circulating myeloid derived suppressor cells in COVID-19 patients.
Kiaee F; Jamaati H; Shahi H; Roofchayee ND; Varahram M; Folkerts G; Garssen J; Adcock IM; Mortaz E
Sci Rep; 2022 Dec; 12(1):22570. PubMed ID: 36581679
[TBL] [Abstract][Full Text] [Related]
9. Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19.
Jiménez-Cortegana C; Liró J; Palazón-Carrión N; Salamanca E; Sojo-Dorado J; de la Cruz-Merino L; Pascual Á; Rodríguez-Baño J; Sánchez-Margalet V
Viral Immunol; 2021 Nov; 34(9):639-645. PubMed ID: 34529510
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good.
Grassi G; Notari S; Gili S; Bordoni V; Casetti R; Cimini E; Tartaglia E; Mariotti D; Agrati C; Sacchi A
Front Immunol; 2022; 13():842949. PubMed ID: 35572540
[TBL] [Abstract][Full Text] [Related]
11. Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan.
Takano T; Matsumura T; Adachi Y; Terahara K; Moriyama S; Onodera T; Nishiyama A; Kawana-Tachikawa A; Miki S; Hosoya-Nakayama K; Nakamura-Hoshi M; Seki S; Tachikawa N; Yoshimura Y; Miyata N; Horiuchi H; Sasaki H; Miyazaki K; Kinoshita N; Sudo T; Akiyama Y; Sato R; Suzuki T; Matano T; Takahashi Y
Int Immunol; 2021 Mar; 33(4):241-247. PubMed ID: 33538817
[TBL] [Abstract][Full Text] [Related]
12. Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells Correlate with Early Infections and Clinical Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation.
Lee SE; Lim JY; Kim TW; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Shin DM; Choi EY; Min CK
Biol Blood Marrow Transplant; 2018 Jan; 24(1):32-42. PubMed ID: 28844945
[TBL] [Abstract][Full Text] [Related]
13. Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization.
Jiménez-Cortegana C; Salamanca E; Palazón-Carrión N; Sánchez-Jiménez F; Pérez-Pérez A; Vilariño-García T; Fuentes S; Martín S; Jiménez M; Galván R; Rodríguez-Chacón C; Sánchez-Mora C; Moreno-Mellado E; Gutiérrez-Gutiérrez B; Álvarez N; Sosa A; Garnacho-Montero J; de la Cruz-Merino L; Rodríguez-Baño J; Sánchez-Margalet V
Front Immunol; 2023; 14():1266659. PubMed ID: 38035104
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer.
Sasidharan Nair V; Saleh R; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Alajez NM; Abu Nada M; Elkord E
Clin Epigenetics; 2020 Jan; 12(1):13. PubMed ID: 31941522
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-Derived Suppressor Cells in Sepsis.
Schrijver IT; Théroude C; Roger T
Front Immunol; 2019; 10():327. PubMed ID: 30873175
[TBL] [Abstract][Full Text] [Related]
16. Respiratory and systemic monocytes, dendritic cells, and myeloid-derived suppressor cells in COVID-19: Implications for disease severity.
Falck-Jones S; Österberg B; Smed-Sörensen A
J Intern Med; 2023 Feb; 293(2):130-143. PubMed ID: 35996885
[TBL] [Abstract][Full Text] [Related]
17. Single-Cell RNA-seq of Human Myeloid-Derived Suppressor Cells in Late Sepsis Reveals Multiple Subsets With Unique Transcriptional Responses: A Pilot Study.
Darden DB; Bacher R; Brusko MA; Knight P; Hawkins RB; Cox MC; Dirain ML; Ungaro R; Nacionales DC; Rincon JC; Gauthier ML; Kladde M; Bihorac A; Brusko TM; Moore FA; Brakenridge SC; Mohr AM; Moldawer LL; Efron PA
Shock; 2021 May; 55(5):587-595. PubMed ID: 33021571
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Myeloid-derived Suppressor Cells in the Blood of Iranian COVID-19 Patients.
Mortaz E; Movassaghi M; Bassir A; Dezfuli NK; Roofchayee ND; Jamaati H; Garssen J; Adcock IM
Iran J Allergy Asthma Immunol; 2022 Aug; 21(4):467-477. PubMed ID: 36243935
[TBL] [Abstract][Full Text] [Related]
19. New Discovery of Myeloid-Derived Suppressor Cell's Tale on Viral Infection and COVID-19.
Park SJ; Nam DE; Seong HC; Hahn YS
Front Immunol; 2022; 13():842535. PubMed ID: 35185933
[TBL] [Abstract][Full Text] [Related]
20. Elevated frequencies of CD14
Xue G; Jiang M; Zhao R; Le A; Li J
Aging (Albany NY); 2021 Feb; 13(5):6236-6246. PubMed ID: 33640878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
